SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is surging after delivering a robust earnings beat, significantly raising its fiscal 2027 revenue guidance, and reporting record remaining performance obligations driven by accelerating AI cloud demand. The community is actively discussing Oracle's solidified position as a major AI infrastructure provider, with bullish sentiment prevailing despite some calls for caution regarding potential pullbacks.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health Inc. is trending as its partnership with Novo Nordisk and the dismissal of a patent lawsuit have significantly de-risked its GLP-1 business, fueling widespread community discussion about a potential short squeeze. Investors are actively debating the stock's undervaluation and substantial upside, further sparked by a new executive hire from Eli Lilly.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is trending as its new high-power Gallium Nitride and Silicon Carbide solutions are gaining attention for their critical role in next-generation AI data centers and NVIDIA's 800V architecture. The community is actively discussing the immense future growth potential and a possible short squeeze, though some remain cautious about current revenues and the need for significant contract announcements.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is rallying on reports of surging China-made EV sales in February and a new partnership with Google, sparking bullish calls for a short squeeze and a technical breakout, though critics continue to highlight ongoing profitability concerns, executive departures, and FSD development challenges.

TSS, Inc. engages in the provision of comprehensive services for the planning, design, development and maintenance of mission-critical facilities and information infrastructure as well as integration services. It operates through the Facilities and Systems Integration Services business segments. The Facilities segment consists of the design, project management, and maintenance of data center and mission-critical business operations. The Systems Integration segment integrates information technology equipment for original equipment manufacturer vendors and customers to be used inside data center environments, including modular data centers. The company was founded by Gerard J. Gallagher on December 20, 2004 and is headquartered in Round Rock, TX.

TSS Inc

TSS Inc. (TSSI) is trending following a strong fourth-quarter earnings beat and the extension of its key AI rack integration agreement with Dell, fueling community excitement about its operational turnaround. Investors are discussing the company's accelerating systems integration business, driven by booming AI infrastructure demand, and the potential for a significant short squeeze.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is surging after announcing a strategic partnership and $2 billion investment from NVIDIA to rapidly scale its full-stack AI cloud infrastructure, alongside final approval for a massive 1.2-gigawatt AI factory in Independence, Missouri. The community is highly bullish, viewing NVIDIA's confidence and Nebius's ability to secure upfront customer payments as significant validation, with many anticipating a short squeeze and substantial long-term growth in the surging AI infrastructure market.

AeroVironment, Inc. engages in the design, development, and production of multi-domain robotic systems and related services for government agencies and businesses. It operates through the following business segments: UnCrewed Systems, Loitering Munitions Systems, and MacCready Work. The UnCrewed Systems segment focuses primarily on small UAS products designed to operate reliably at lower altitudes in a wide range of environmental conditions. The Loitering Munitions Systems segment focuses primarily on tube-launched aircraft that deploy with the push of a button, fly at higher speeds than small UAS products, and perform either effects delivery or reconnaissance missions, and related support services including training, spare parts, product repair, and product replacement. The MacCready Works segment focuses on customer-funded research and development in the areas of HAPS, robotics, sensors, software analytics, data intelligence, and connectivity. The company was founded by Paul B. MacCready, Jr. in July 1971 and is headquartered in Arlington, VA.

AeroVironment Inc.

AeroVironment's recent earnings miss and lowered guidance, specifically impacted by the US Space Force terminating the SCAR contract, are driving current conversations; however, many investors believe the market has disproportionately reacted, highlighting strong demand for defense drones amid global tensions and ongoing efforts to secure the SCAR program.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

Historic proposed oil reserve releases by the IEA and rising U.S. inventories are clashing with ongoing geopolitical tensions and reports of potential mining in the Strait of Hormuz, creating intense volatility and sharply dividing the community on the future direction of oil prices.

The Campbell's Co. engages in the business of manufacturing and marketing food and beverage products. It operates under the Meals and Beverages, and Snacks segments. The Meals and Beverages segment includes soup, meals, and beverage products in retail and foodservice. The Snacks segment offers cookies, crackers, bakery, and frozen products. The company was founded by Joseph Campbell and Abraham Anderson in 1869 and is headquartered in Camden, NJ.

Campbells Co (The)

Campbell Soup Co.

Campbell Soup Co. is trending after reporting a disappointing Q2, missing earnings and revenue estimates, and subsequently lowering its full-year profit and organic sales outlook primarily due to weaker snack performance. This has ignited community debate, with many expressing deep concern about the company's trajectory and broader sector headwinds, while others are bottom-fishing at multi-decade lows, citing strong brands like Rao's and potential tariff relief as long-term tailwinds.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is experiencing choppy, range-bound trading amid geopolitical tensions in the Middle East, with community participants debating market manipulation and the uncertain impact of emergency oil reserve releases and conflicting reports on the conflict's resolution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Guggenheim Forecasts Strong Price Appreciation for Jade Biosciences (NASDAQ:JBIO) Stock

Guggenheim lifted their price target on shares of Jade Biosciences from $17.00 to $23.00 and gave the company a "buy" rating in a research note on Wednesday...

Jade Biosciences (NASDAQ:JBIO) Sees Unusually-High Trading Volume Following Analyst Upgrade

Jade Biosciences (NASDAQ:JBIO) Sees Strong Trading Volume on Analyst Upgrade...

Wedbush Reaffirms Outperform Rating for Jade Biosciences (NASDAQ:JBIO)

Wedbush reissued an "outperform" rating and issued a $24.00 price target on shares of Jade Biosciences in a research report on Monday...

Jade Biosciences, Inc. (NASDAQ:JBIO) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Jade Biosciences, Inc. (NASDAQ:JBIO - Get Free Report) has received an average rating of "Moderate Buy" from the seven ratings firms that are presently covering the firm, MarketBeat.com reports. One...

Jade Biosciences (NASDAQ:JBIO) Upgraded by Lifesci Capital to "Strong-Buy" Rating

Lifesci Capital raised Jade Biosciences to a "strong-buy" rating in a research report on Friday...

Jade Biosciences Touts Best-in-Class Autoimmune Antibodies, JADE101 Phase 1 Readout Nears

Jade Biosciences (NASDAQ:JBIO) outlined its strategy and near-term milestones at the Oppenheimer Life Sciences Conference, where CEO Tom Frohlich described the company's focus on developing...

Jade Biosciences (NASDAQ:JBIO) Shares Gap Up - Here's Why

Jade Biosciences (NASDAQ:JBIO) Shares Gap Up - Should You Buy...

Jade Biosciences, Inc. (NASDAQ:JBIO) Short Interest Update

Jade Biosciences, Inc. (NASDAQ:JBIO - Get Free Report) saw a significant decrease in short interest in January. As of January 15th, there was short interest totaling 1,345,619 shares, a decrease of...

Jade Biosciences (NASDAQ:JBIO) Stock Price Down 5.3% - Here's What Happened

Jade Biosciences (NASDAQ:JBIO) Trading Down 5.3% - Should You Sell...

Short Interest in Jade Biosciences, Inc. (NASDAQ:JBIO) Increases By 47.9%

Jade Biosciences, Inc. (NASDAQ:JBIO - Get Free Report) was the target of a large increase in short interest in December. As of December 31st, there was short interest totaling 1,546,739 shares, an...

Jade Biosciences, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. The company was founded by Benjamin T. Dake on July 27, 2018 and is headquartered in Waltham, MA.

Current Price	$14.40
Prev Close	$14.48
Open	$14.88
Dividend Yield	0.00%
50-Day Moving Average	$14.79
Beta	-1.24
Avg. Volume	234,297.11
PE Ratio	-2.65

52-Week High	$100.10
52-Week Low	$6.57
Market Capitalization	$714.1M
EPS (Annual)	-$4.06
Price to Book	2.15
Revenue Per Employee	$0.00

JBIO
Jade Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest JBIO News

JBIOJade Biosciences Inc